EV/EBITDA
-0.07
0.000.00%
4 min ago
Summary
- As of February 26, 2025, SYRS EV/EBITDA is -0.07, unchanged from the previous trading day.
- Over the past year, SYRS EV/EBITDA has increased by +0.72 (+91.14%).
- SYRS EV/EBITDA is now -112.50% below its all-time high of 0.56.
Performance
SYRS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SYRS EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | 0.0% | +1.6% | +2.3% |
1 m1 month | +22.2% | -19.8% | -26.4% |
3 m3 months | +22.2% | -26.6% | -34.5% |
6 m6 months | +66.7% | -76.4% | -90.4% |
ytdytd | +22.2% | -23.6% | -30.9% |
1 y1 year | +91.1% | -95.0% | -97.9% |
5 y5 years | +98.1% | -97.6% | -99.8% |
SYRS EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | at high | -0.09 | +22.2% | |
3 m | 3-month | -0.07 | at high | -0.10 | +30.0% |
6 m | 6-month | -0.07 | at high | -1.02 | +93.1% |
1 y | 1-year | -0.07 | at high | -1.29 | +94.6% |
3 y | 3-year | 0.56 | -112.5% | -1.50 | +95.3% |
5 y | 5-year | 0.56 | -112.5% | -11.54 | +99.4% |
alltime | all time | 0.56 | -112.5% | -11.54 | +99.4% |
Syros Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | -0.07(-22.2%) |
2024 | -0.09(-89.3%) |
2023 | -0.84(-333.3%) |
2022 | 0.36(-116.4%) |
2021 | -2.20(-65.3%) |
Date | Value |
---|---|
2020 | -6.34(+62.1%) |
2019 | -3.91(+71.5%) |
2018 | -2.28(-46.1%) |
2017 | -4.23(-12.6%) |
2016 | -4.84 |
FAQ
- What is Syros Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Syros Pharmaceuticals?
- What is SYRS EV/EBITDA year-to-date change?
- What is Syros Pharmaceuticals EV/EBITDA year-on-year change?
What is Syros Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SYRS is -0.07
What is the all time high EV/EBITDA for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high EV/EBITDA is 0.56
What is SYRS EV/EBITDA year-to-date change?
Syros Pharmaceuticals EV/EBITDA has changed by +0.02 (+22.22%) since the beginning of the year
What is Syros Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SYRS EV/EBITDA has changed by +0.72 (+91.14%)